219 related articles for article (PubMed ID: 22528792)
21. Intracerebral malignant peripheral nerve sheath tumor in a child with neurofibromatosis Type 1 and middle cerebral artery aneurysm treated with endovascular coil embolization.
Ellis MJ; Cheshier S; Sharma S; Armstrong D; Hawkins C; Bouffet E; Rutka JT; Taylor MD
J Neurosurg Pediatr; 2011 Oct; 8(4):346-52. PubMed ID: 21961539
[TBL] [Abstract][Full Text] [Related]
22. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.
Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J
Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697
[TBL] [Abstract][Full Text] [Related]
23. Malignant peripheral nerve sheath tumor on a patient with a maternally inherited novel NF1 gene pathogenic germline variant: Case report.
Moreno-Salgado R; Rios-Lozano YZ; Tamayo-Palacio AC; Castillo AI; Hidalgo-Martínez MF
Cancer Genet; 2023 Jun; 274-275():72-74. PubMed ID: 37087941
[TBL] [Abstract][Full Text] [Related]
24. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
[TBL] [Abstract][Full Text] [Related]
25. The role of magnetic resonance imaging in the diagnostic evaluation of malignant peripheral nerve sheath tumors.
Chhabra A; Soldatos T; Durand DJ; Carrino JA; McCarthy EF; Belzberg AJ
Indian J Cancer; 2011; 48(3):328-34. PubMed ID: 21921333
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Jones J; Cain S; Pesic-Smith J; Choong PFM; Morokoff AP; Drummond KJ; Dabscheck G
J Neurooncol; 2021 Sep; 154(3):265-274. PubMed ID: 34529228
[TBL] [Abstract][Full Text] [Related]
27. The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs).
Upadhyaya M; Spurlock G; Majounie E; Griffiths S; Forrester N; Baser M; Huson SM; Gareth Evans D; Ferner R
Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786508
[TBL] [Abstract][Full Text] [Related]
28. Osteosarcoma in a patient with neurofibromatosis type 1: a case report and review of the literature.
Hatori M; Hosaka M; Watanabe M; Moriya T; Sasano H; Kokubun S
Tohoku J Exp Med; 2006 Apr; 208(4):343-8. PubMed ID: 16565597
[TBL] [Abstract][Full Text] [Related]
29. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
Dunn GP; Spiliopoulos K; Plotkin SR; Hornicek FJ; Harmon DC; Delaney TF; Williams Z
J Neurosurg; 2013 Jan; 118(1):142-8. PubMed ID: 23101443
[TBL] [Abstract][Full Text] [Related]
30. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
31. STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.
Somatilaka BN; Madana L; Sadek A; Chen Z; Chandrasekaran S; McKay RM; Le LQ
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38502231
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
[TBL] [Abstract][Full Text] [Related]
33. Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.
Farschtschi S; Kluwe L; Park SJ; Oh SJ; Mah N; Mautner VF; Kurtz A
Cancer Immunol Immunother; 2020 Jul; 69(7):1307-1313. PubMed ID: 32193699
[TBL] [Abstract][Full Text] [Related]
34. Intrathoracic malignant peripheral nerve sheath tumor with angiosarcoma in a child with NF1.
Elli M; Can B; Ceyhan M; Pinarli FG; Dagdemir A; Ayyildiz HS; Gürsel B; Dagçinar A
Tumori; 2007; 93(6):641-4. PubMed ID: 18338507
[TBL] [Abstract][Full Text] [Related]
35. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.
Bilgic B; Ates LE; Demiryont M; Ozger H; Dizdar Y
Pathol Oncol Res; 2003; 9(3):201-5. PubMed ID: 14530818
[TBL] [Abstract][Full Text] [Related]
36. A case of intra-dural malignant peripheral nerve sheath tumor in thoracic spine associated with neurofibromatosis type 1.
Albayrak BS; Gorgulu A; Kose T
J Neurooncol; 2006 Jun; 78(2):187-90. PubMed ID: 16598431
[TBL] [Abstract][Full Text] [Related]
37. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
38. A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours.
Martin E; Coert JH; Flucke UE; Slooff WM; Ho VKY; van der Graaf WT; van Dalen T; van de Sande MAJ; van Houdt WJ; Grünhagen DJ; Verhoef C
Eur J Cancer; 2020 Jan; 124():77-87. PubMed ID: 31760312
[TBL] [Abstract][Full Text] [Related]
39. Giant malignant nerve sheath tumor of lumbosacral plexus with intraspinal extension in a child with neurofibromatosis type 1.
Pratap A; Nepal P; Agrawal A; Singh MP; Pandey SR
Pediatr Neurosurg; 2007; 43(5):410-3. PubMed ID: 17786009
[TBL] [Abstract][Full Text] [Related]
40. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]